MINI FUTURE OPTIONSSCHEIN PUT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000DJ4WG69

Delayed Deutsche Boerse AG 10:04:35 11/07/2024 pm IST
1.15 EUR -1.71% Intraday chart for MINI FUTURE OPTIONSSCHEIN PUT - FRESENIUS MEDICAL CARE
Current month-4.10%
1 month+37.65%
Date Price Change
11/24/11 1.15 -1.71%
10/24/10 1.17 -3.31%
09/24/09 1.21 +0.83%
08/24/08 1.2 +2.56%
05/24/05 1.17 -2.50%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 10:04 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ4WG6
ISINDE000DJ4WG69
Date issued 16/08/2023
Strike 47.9
Maturity Unlimited
Parity 10 : 1
Emission price 0.371
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.82
Lowest since issue 0.34
Spread 0.02
Spread %1.71%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.22 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.36%
Consensus